Sign in
4

Changes in Ownership

Taysha Gene Therapies, Inc. Filed Acc 0001209191-23-017342

10% owner acquired 251,296 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Session R.A. II 10% owner 2023-03-06 Other acquisition +251,296 9,420,842 D
Derivatives
Session R.A. II 10% owner 2023-03-06 Returned to the company · Employee Stock Option (right to buy) −199,500 0 D
Loading xslF345X03/doc4.xml…